Viewing Study NCT01211002


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-02-20 @ 10:58 PM
Study NCT ID: NCT01211002
Status: UNKNOWN
Last Update Posted: 2010-09-29
First Post: 2010-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor: Simcere Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module